181 related articles for article (PubMed ID: 19671749)
1. Enhanced targeting with heterobivalent ligands.
Xu L; Vagner J; Josan J; Lynch RM; Morse DL; Baggett B; Han H; Mash EA; Hruby VJ; Gillies RJ
Mol Cancer Ther; 2009 Aug; 8(8):2356-65. PubMed ID: 19671749
[TBL] [Abstract][Full Text] [Related]
2. Cell-specific targeting by heterobivalent ligands.
Josan JS; Handl HL; Sankaranarayanan R; Xu L; Lynch RM; Vagner J; Mash EA; Hruby VJ; Gillies RJ
Bioconjug Chem; 2011 Jul; 22(7):1270-8. PubMed ID: 21639139
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.
Alleti R; Vagner J; Dehigaspitiya DC; Moberg VE; Elshan NG; Tafreshi NK; Brabez N; Weber CS; Lynch RM; Hruby VJ; Gillies RJ; Morse DL; Mash EA
Bioorg Med Chem; 2013 Sep; 21(17):5029-38. PubMed ID: 23890524
[TBL] [Abstract][Full Text] [Related]
4. Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors.
Vagner J; Xu L; Handl HL; Josan JS; Morse DL; Mash EA; Gillies RJ; Hruby VJ
Angew Chem Int Ed Engl; 2008; 47(9):1685-8. PubMed ID: 18205159
[No Abstract] [Full Text] [Related]
5. Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactions.
De Silva CR; Vagner J; Lynch R; Gillies RJ; Hruby VJ
Anal Biochem; 2010 Mar; 398(1):15-23. PubMed ID: 19852924
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin 4 receptors interact with antimicrobial frog peptide analogues.
Do EU; Jo EB; Choi G; Piao LZ; Shin J; Seo MD; Kang SJ; Lee BJ; Kim KH; Kim JB; Kim SI
Biochem Biophys Res Commun; 2006 May; 343(4):1094-100. PubMed ID: 16579969
[TBL] [Abstract][Full Text] [Related]
7. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R).
Handl HL; Sankaranarayanan R; Josan JS; Vagner J; Mash EA; Gillies RJ; Hruby VJ
Bioconjug Chem; 2007; 18(4):1101-9. PubMed ID: 17591746
[TBL] [Abstract][Full Text] [Related]
9. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
10. Heterobivalent ligands target cell-surface receptor combinations in vivo.
Xu L; Josan JS; Vagner J; Caplan MR; Hruby VJ; Mash EA; Lynch RM; Morse DL; Gillies RJ
Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21295-300. PubMed ID: 23236171
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
Fernandes SM; Lee YS; Gillies RJ; Hruby VJ
Bioorg Med Chem; 2014 Nov; 22(22):6360-5. PubMed ID: 25438759
[TBL] [Abstract][Full Text] [Related]
13. The interaction of MC3R and MC4R with MRAP2, ACTH, α-MSH and AgRP in chickens.
Zhang J; Li X; Zhou Y; Cui L; Li J; Wu C; Wan Y; Li J; Wang Y
J Endocrinol; 2017 Aug; 234(2):155-174. PubMed ID: 28512117
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, tissue distribution, and pharmacological characterization of melanocortin-4 receptor in spotted scat, Scatophagus argus.
Li JT; Yang Z; Chen HP; Zhu CH; Deng SP; Li GL; Tao YX
Gen Comp Endocrinol; 2016 May; 230-231():143-52. PubMed ID: 27080551
[TBL] [Abstract][Full Text] [Related]
15. Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor.
Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
Anal Biochem; 2005 Aug; 343(2):299-307. PubMed ID: 16004955
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway.
Caruso C; Carniglia L; Durand D; Gonzalez PV; Scimonelli TN; Lasaga M
Mol Cell Endocrinol; 2012 Jan; 348(1):47-54. PubMed ID: 21803120
[TBL] [Abstract][Full Text] [Related]
17. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
18. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.
Haskell-Luevano C; Holder JR; Monck EK; Bauzo RM
J Med Chem; 2001 Jun; 44(13):2247-52. PubMed ID: 11405661
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors.
Lee EJ; Lee SH; Jung JW; Lee W; Kim BJ; Park KW; Lim SK; Yoon CJ; Baik JH
Eur J Biochem; 2001 Feb; 268(3):582-91. PubMed ID: 11168397
[TBL] [Abstract][Full Text] [Related]
20. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
